European Journal of Neurology

Cover image for Vol. 24 Issue 10

Edited By: Tony Schapira

Impact Factor: 3.988

ISI Journal Citation Reports © Ranking: 2016: 40/194 (Clinical Neurology); 66/258 (Neurosciences)

Online ISSN: 1468-1331

OnlineOpen Articles


Automatic detection of paroxysmal atrial fibrillation in patients with ischaemic stroke: better than routine diagnostic workup?
T. Uphaus, A. Grings, S. Gröschel, A. Müller, M. Weber-Krüger, R. Wachter and K. Gröschel

Mesiotemporal atrophy and hippocampal diffusivity distinguish amnestic from non-amnestic vascular cognitive impairment
A. A. Hosseini, D. Meng, R. J. Simpson and D. P. Auer

Headache patients’ satisfaction with telemedicine: a 12-month follow-up randomized non-inferiority trial
K. I. Müller, K. B. Alstadhaug and S. I. Bekkelund

Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing–remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studies
E. Havrdova, G. Giovannoni, R. Gold, R. J. Fox, L. Kappos, J. Theodore Phillips, M. Okwuokenye and J. L. Marantz

People with epilepsy obtain added value from education in groups: results of a qualitative study
L. Ridsdale, S. J. Philpott, A.-M. Krooupa and M. Morgan

Efficacy of pallidal stimulation in isolated dystonia: a systematic review and meta-analysis
E. Moro, C. LeReun, J. K. Krauss, A. Albanese, J.-P. Lin, S. Walleser Autiero, T. C. Brionne and M. Vidailhet

Low-dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients
A. S. Schoonjans, B. P. Paelinck, F. Marchau, B. Gunning, A. Gammaitoni, B. S. Galer, L. Lagae and B. Ceulemans

Ongoing impairments following transient ischaemic attack: retrospective cohort study
G. M. Turner, M. Calvert, M. G. Feltham, R. Ryan and T. Marshall

Chiropractic spinal manipulative therapy for migraine: a three-armed, single-blinded, placebo, randomized controlled trial
A. Chaibi, J. Š. Benth, P. J. Tuchin and M. B. Russell

Clinical and genetic characterization of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia associated with CSF1R mutation
T. Konno, K. Yoshida, T. Mizuno, T. Kawarai, M. Tada, H. Nozaki, S.-I. Ikeda, M. Nishizawa, O. Onodera, Z. K. Wszolek and T. Ikeuchi

Impulse control disorder related behaviours during long-term rotigotine treatment: a post hoc analysis
A. Antonini, K. R. Chaudhuri, B. Boroojerdi, M. Asgharnejad, L. Bauer, F. Grieger and D. Weintraub

The societal cost of Huntington's disease: are we underestimating the burden?
C. Jones, M. Busse, L. Quinn, H. Dawes, C. Drew, M. Kelson, K. Hood, A. Rosser and R. T. Edwards

Do white matter hyperintensities mediate the association between brain iron deposition and cognitive abilities in older people?
M. Valdés Hernández, M. Allerhand, A. Glatz, L. Clayson, S. Muñoz Maniega, A. Gow, N. Royle, M. Bastin, J. Starr, I. Deary and J. Wardlaw

A population-based study comparing multiple sclerosis clinic users and non-users in British Columbia, Canada
K. A. McKay, H. Tremlett, F. Zhu, L. Kastrukoff, R. A. Marrie and E. Kingwell

Depression, anxiety, and apathy in Parkinson's disease: insights from neuroimaging studies
M.-C. Wen, L. L. Chan, L. C. S. Tan and E. K. Tan

The effect of pedunculopontine nucleus deep brain stimulation on postural sway and vestibular perception
N. Yousif, H. Bhatt, P. G. Bain, D. Nandi and B. M. Seemungal

Can the cardiovascular family history reported by our patients be trusted? The Norwegian Stroke in the Young Study
H. Øygarden, A. Fromm, K. M. Sand, G. E. Eide, L. Thomassen, H. Naess and U. Waje-Andreassen

Predominance of caudate nucleus lesions in acute ischaemic stroke patients with impairment in language and speech
E. O. Grönholm, M. C. Roll, M. A. Horne, P. C. Sundgren and A. G. Lindgren

Factors associated with recurrent stroke and recanalization in patients presenting with isolated symptomatic carotid occlusion
D. Damania, N. T.-M. Kung, M. Jain, A. R. Jain, J. A. Liew, R. Mangla, G. E. Koch, B. Sahin, A. S. Miranpuri, T. M. Holmquist, R. E. Replogle, C. G. Benesch, A. G. Kelly and B. S. Jahromi

Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis
A. E. Elia, S. Lalli, M. R. Monsurrò, A. Sagnelli, A. C. Taiello, B. Reggiori, V. La Bella, G. Tedeschi and A. Albanese

Disease-modifying treatments for multiple sclerosis – a review of approved medications
Ø. Torkildsen, K.-M. Myhr and L. Bø

Surgically implanted and non-invasive vagus nerve stimulation: a review of efficacy, safety and tolerability
E. Ben-Menachem, D. Revesz, B. J. Simon and S. Silberstein

A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patients
P. Barone, G. Santangelo, L. Morgante, M. Onofrj, G. Meco, G. Abbruzzese, U. Bonuccelli, G. Cossu, G. Pezzoli, P. Stanzione, L. Lopiano, A. Antonini and M. Tinazzi

Characteristics in childhood and adolescence associated with future multiple sclerosis risk in men: cohort study
M. Gunnarsson, R. Udumyan, S. Bahmanyar, Y. Nilsagård and S. Montgomery

Beta-interferon exposure and onset of secondary progressive multiple sclerosis
T. Zhang, A. Shirani, Y. Zhao, M. E. Karim, P. Gustafson, J. Petkau, C. Evans, E. Kingwell, M. van der Kop, F. Zhu, J. Oger, H. Tremlett and BC MS Clinic Neurologists

Time course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosis
L. Kappos, G. Giovannoni, R. Gold, J. T. Phillips, D. L. Arnold, C. Hotermans, A. Zhang, V. Viglietta, R. J. Fox and for the DEFINE and CONFIRM study investigators

Obesity interacts with infectious mononucleosis in risk of multiple sclerosis
A. K. Hedström, I. Lima Bomfim, J. Hillert, T. Olsson and L. Alfredsson

Natalizumab improves ambulation in relapsing−remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM
N. Voloshyna, E. Havrdová, M. Hutchinson, T. Nehrych, X. You, S. Belachew, C. Hotermans and D. Paes

Cognitive motor interference for gait and balance in stroke: a systematic review and meta-analysis
X.-Q. Wang, Y.-L. Pi, B.-L Chen, P.-J. Chen, Y. Liu, R. Wang, X. Li and G. Waddington

Comparing ischaemic stroke in six European countries. The EuroHOPE register study
A. Malmivaara, A. Meretoja, M. Peltola, D. Numerato, R. Heijink, P. Engelfriet, S. H. Wild, É. Belicza, D. Bereczki, E. Medin, F. Goude, G. Boncoraglio, T. Tatlisumak, T. Seppälä and U. Häkkinen

Serum 25-hydroxyvitamin D and cognitive decline in the very old: the Newcastle 85+ Study
A. Granic, T. R. Hill, T. B. L. Kirkwood, K. Davies, J. Collerton, C. Martin-Ruiz, T. von Zglinicki, B. K. Saxby, K. A. Wesnes, D. Collerton, J. C. Mathers and C. Jagger

Move for Change Part III: a European survey evaluating the impact of the EPDA Charter for People with Parkinson's Disease
B. R. Bloem and F. Stocchi

Dipyridamole-induced headache and lower recurrence risk in secondary prevention of ischaemic stroke: a post hoc analysis
G. Davidai, D. Cotton, P. Gorelick, P. M. W. Bath, R. B. Lipton, R. Sacco and H.-C. Diener

Total drug treatment and comorbidity in myasthenia gravis: a population-based cohort study
J. B. Andersen, J. F. Owe, A. Engeland and N. E. Gilhus

Dipyridamole-induced headache and lower recurrence risk in secondary prevention of ischaemic stroke: a post hoc analysis
G. Davidai, D. Cotton, P. Gorelick, P. M. W. Bath, R. B. Lipton, R. Sacco and H.-C. Diener

Total drug treatment and comorbidity in myasthenia gravis: a population-based cohort study
J. B. Andersen, J. F. Owe, A. Engeland and N. E. Gilhus

Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine
H.-C. Diener, D. W. Dodick, C. C. Turkel, G. Demos, R. E. DeGryse, N. L. Earl and M. F. Brin

Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease
R. A. Hauser A. H. V. Schapira P. Barone Y. Mizuno O. Rascol M. Busse C. Debieuvre M. Fraessdorf W. Poewe8 and for the Pramipexole ER Studies Group

Treatment options for patients with multiple sclerosis who have a suboptimal response to interferon-β therapy
M. S. Freedman

The Dystonia Discomfort Scale (DDS): a novel instrument to monitor the temporal profile of botulinum toxin therapy in cervical dystonia
D. Dressler, A. Kupsch, A. Seitzinger and S. Paus

Bell's palsy and sudden deafness associated with Rickettsia spp. infection in Sweden. A retrospective and prospective serological survey including PCR findings
K. Nilsson, K. Wallménius, S. Hartwig, T. Norlander and C. Påhlson

Move for Change Part II: a European survey evaluating the impact of the EPDA Charter for people with Parkinson's disease
F. Stocchi, and B. R. Bloem